Carbon-Ion Radiotherapy for Prostate Cancer in Hemodialysis Patients
CIRT for prostate cancer can be safely administered even in hemodialysis patients, and its toxicities were within acceptable limits. Our findings suggest that CIRT has potential as a treatment option for this patient population.
Authors
- Hiroaki Suefuji (ORCID: https://orcid.org/0000-0002-1574-5510)
- K. Fukunishi
- Yoshiyuki Shioyama (ORCID: https://orcid.org/0000-0002-9202-1225)
- Shingo Toyama (ORCID: https://orcid.org/0000-0003-2646-3014)
- Akira Matsunobu
- Hitomi Imafuku (ORCID: https://orcid.org/0000-0001-5463-0452)
- WAKANA OTA
- Kotaro Terashima
Institutions
- Kyushu University Hospital (JP)
- SAGA Heavy Ion Medical Accelerator in Tosu (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17794
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00